Klotigo 500 mg,1 000 mg Solution for injection/ infusion
PDF Leaflet Revision Date: 29 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of haemorrhage or risk of haemorrhage in increased fibrinolysis.
Dosage (summary)
0.5-1g IV 2-3 times daily; adjust for renal impairment.
Special Populations
- Renal impairment
- Paediatric population
Pregnancy & Breastfeeding
Safety in pregnancy not established; avoid breastfeeding.
Key Drug Interactions
- Anticoagulants
- Thrombolytics
Contraindications
- Hypersensitivity
- Severe renal impairment
- Thrombotic tendency
Common side effects
- Visual disturbances
- Dizziness
- Nausea
- Vomiting
Counselling Points
- Use effective contraception during treatment
- Avoid driving if dizzy
- Report any hypersensitivity reactions
Serious warnings
- Risk of convulsions
- Thromboembolic events
- Monitor for visual disturbances
Important Disclaimer
The Klotigo 500 mg,1 000 mg Solution for injection/ infusion professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
